Surgical menopause usually happens when both ovaries are removed before natural menopause, causing ovarian hormone levels to fall quickly. Menopause hormone therapy (MHT), also called hormone replacement therapy (HRT), may be considered for symptoms and bone health, but the right plan depends on age, surgery details, whether the uterus remains, and personal health risks 1.
Wondering if hormone therapy is right for you? Take the 3-min clinical quiz.
See if you qualify →What is surgical menopause, and when does it happen?
Surgical menopause occurs when both ovaries are removed, a procedure called bilateral oophorectomy. The ovaries normally produce estrogen and other hormones before menopause. Their removal can cause a rapid hormone change rather than the gradual transition of natural menopause 1.
Surgery may remove the ovaries because of a mass, cancer risk, endometriosis, severe pelvic pain, or another condition. The reason for surgery matters: for example, a history of hormone-sensitive cancer can substantially change the hormone therapy conversation 1.
Does hysterectomy always cause surgical menopause?
No. A hysterectomy removes the uterus. If one or both ovaries remain, they may continue producing hormones, so hysterectomy by itself does not necessarily cause immediate menopause. Review the operative report with your surgeon or menopause clinician rather than assuming which organs were removed 1.
What changes when both ovaries are removed?
After both ovaries are removed before natural menopause, estrogen production drops quickly. This can bring on menopause symptoms and may affect bone turnover sooner than a gradual transition would. Earlier menopause is also linked with greater long-term bone-health concerns, which is one reason clinicians discuss bone mineral density and hormone therapy on an individualized basis 12.
Why can surgical menopause symptoms feel sudden or intense?
Symptoms can feel stronger because there is no gradual decline in ovarian hormone production. The first weeks after surgery may be a time when hot flashes, sleep disruption, and vaginal symptoms become noticeable, although each person's experience differs 1.
Common short-term symptoms to discuss with a clinician
- Hot flashes and night sweats, together called vasomotor symptoms 1.
- Sleep disruption, which may be related to night sweats or other recovery factors 1.
- Vaginal dryness, discomfort with sex, or urinary symptoms related to genitourinary changes of menopause 1.
- Mood changes, concentration concerns, or fatigue, which can have many causes during surgical recovery and deserve a full clinical review 1.
Why age at surgery and the reason for surgery matter
Age at surgery is central to the benefit-risk discussion. The Menopause Society notes that treatment decisions should account for age, time since menopause, symptoms, personal risks, and treatment goals rather than applying one rule to everyone 1. A person who had surgery for a hormone-sensitive condition needs a different discussion than someone whose surgery was for a noncancerous reason.
Can HRT help after surgical menopause?
Yes, menopause hormone therapy may be considered to manage menopause symptoms after surgical menopause and to address bone-loss concerns in appropriate patients. Hormone therapy is the most effective treatment for vasomotor symptoms, but it is not a guarantee of symptom relief and should be weighed against personal risks 1.
What evidence says about menopause symptom treatment
MHT includes estrogen therapy alone or estrogen paired with a progestogen. Estradiol is an estrogen; progesterone is a progestogen. Professional guidance supports individualized MHT for bothersome symptoms when the expected benefits and risks fit the patient's clinical situation 1.
Potential side effects can include breast tenderness, headache, nausea, bloating, vaginal bleeding, or skin irritation with some delivery systems. More serious risks vary by treatment type and patient history and can include blood clots, stroke, and certain cancer-related concerns; a clinician should review these before prescribing 1.
What evidence says about bone health
Estrogen helps slow bone loss during treatment. In a randomized study of early postmenopausal women receiving hormone replacement therapy, changes in bone-specific alkaline phosphatase were associated with later bone mineral density response 2. Other clinical research has examined hormone therapy for osteoporosis prevention and bone-mass outcomes, including among people with surgical menopause 34.
That does not mean HRT prevents fractures or osteoporosis for any individual. A clinician may consider surgery timing, fracture history, family history, nutrition, exercise, medications, and whether bone-density testing is appropriate. Hormone therapy also has limits and risks, including those described above 1.
What HRT cannot guarantee
HRT cannot promise relief from every symptom, prevent every long-term health outcome, or replace routine preventive care. A randomized trial in postmenopausal women measured changes in peripheral blood-flow velocity with hormone therapy, but that physiologic result does not establish that HRT prevents cardiovascular disease 5. Individual results vary.
3-min quiz
Talk through your surgical-menopause history
If you are considering estradiol or progesterone after ovary removal, Chia's licensed US clinicians can review your history online and prescribe only where clinically appropriate. A prescription is not guaranteed. Medications through Chia are compounded by US state-licensed 503A pharmacies and are not FDA-approved 1.
Does having a uterus change the type of HRT a person may need?
Yes. Whether the uterus remains is one of the most important facts in an HRT evaluation. Systemic estrogen can stimulate the uterine lining, so clinicians typically consider a progestogen for endometrial protection when a uterus is present 1.
| Surgical situation | Hormone discussion a clinician may have | Why it matters |
|---|---|---|
| Both ovaries removed; uterus remains | Estrogen plus a progestogen may be considered | A progestogen may help protect the endometrium during systemic estrogen use 1. |
| Both ovaries and uterus removed | Estrogen-only therapy may be considered in some patients | There is no endometrium to protect, though other risks and benefits still need review 1. |
| Uterus removed; ovaries remain | HRT may not be needed solely because of hysterectomy | Remaining ovaries may continue hormone production until natural menopause 1. |
| One ovary removed | Menopause timing and symptoms need individual assessment | One remaining ovary may continue producing hormones 1. |
Why hysterectomy status should be confirmed before treatment
Your clinician should confirm whether your uterus, cervix, one ovary, or both ovaries remain. Bring the surgery name, pathology report if available, and operative note. This avoids treating a guessed surgical history and helps guide safer decisions about estrogen-only versus estrogen-plus-progestogen therapy 1.
What are the risks and limits of HRT after surgical menopause?
HRT has real trade-offs. Risk depends on timing and personal history, including age, time since menopause, dose and route, history of blood clots or stroke, liver disease, unexplained vaginal bleeding, and some cancers 1.
The Menopause Society recommends periodic reevaluation so treatment remains aligned with symptoms and goals. A prior breast cancer diagnosis, active or past clotting disorder, or other serious condition may mean a clinician recommends a different approach or specialist input 1.
Side effects and symptoms that warrant prompt medical attention
Report side effects to the prescribing clinician, especially new or persistent bleeding. Seek urgent care for symptoms that could suggest a clot or stroke, such as chest pain, sudden shortness of breath, coughing blood, one-sided leg swelling, sudden weakness, trouble speaking, or a severe sudden headache. These symptoms need prompt evaluation regardless of whether you use hormone therapy 1.
What nonhormonal support may be part of care after surgery?
Nonhormonal care can be useful whether or not HRT is appropriate. Regular weight-bearing activity and adequate nutrition support general bone health, while sleep habits, cooling strategies, and counseling may help with some symptoms or adjustment after surgery. These steps do not replace individualized medical care for significant symptoms or high fracture risk 1.
A clinician may also discuss nonhormonal prescription options for vasomotor symptoms, vaginal moisturizers or lubricants for local symptoms, and bone-health assessment when indicated. For a broader overview, see our guide to what hormone replacement therapy is and our explanation of menopause stages and symptoms.
How can you prepare for an HRT discussion after surgical menopause?
A focused appointment can make the decision clearer. Your surgery records and a simple symptom timeline help a clinician understand what changed, what matters most to you, and whether hormone therapy is a reasonable option 1.
- 1Ask exactly what was removed: uterus, cervix, fallopian tubes, one ovary, or both ovaries.
- 2Bring the surgery date, operative note, pathology report, and information about the reason for surgery.
- 3List symptoms, when they began, how often they happen, and how they affect sleep, work, sex, or daily life.
- 4Share all medicines, supplements, allergies, and personal and family history of clots, stroke, breast cancer, uterine cancer, or osteoporosis.
- 5Ask how and when your clinician will reassess benefits, side effects, bleeding, bone health, and treatment goals.
If you are considering virtual care, our guide on how to get HRT safely explains what a clinical evaluation should cover. You can also review common side effects of estrogen and progesterone before an appointment.
How does HRT for surgical menopause work at Chia?
At Chia, we start with the surgical-menopause situation, not a preset regimen. A licensed US provider reviews your health questionnaire online and considers the type and timing of surgery, whether the uterus remains, symptoms, health history, and medical records when available. They prescribe only when clinically appropriate; a prescription is never guaranteed.
Where appropriate, Chia offers compounded estradiol through state-licensed 503A pharmacies in cream, injection, and transdermal patch forms. Plans for estradiol currently start at $109 per month; see the product page for current pricing. Chia also offers compounded progesterone in cream and injection forms, with plans currently starting at $109 per month. Compounded medications are not FDA-approved 1.
| Chia treatment | Available forms | What to know |
|---|---|---|
| Estradiol | Cream, injection, transdermal patch | A clinician determines whether estradiol is appropriate and which form fits the clinical plan. Plans currently start at $109/month. |
| Progesterone | Cream, injection | A clinician determines whether progesterone is needed, including whether the uterus remains. Plans currently start at $109/month. |
| HRT for Women protocol | Estradiol Oral plus Progesterone IR | This listed multi-treatment protocol currently starts at $119/month; clinical eligibility and the appropriate regimen require review. HRT for Women |
If prescribed, medication is compounded in the US by a state-licensed 503A compounding pharmacy and shipped to your door. Dosing is provider-guided and may be adjusted over time, with messaging through the patient portal between visits. Compounded medications are not FDA-approved 1. Our providers may determine that treatment is not appropriate and may recommend in-person or specialist care instead.
Chia's online model can make an evaluation more accessible, but it does not replace urgent postoperative care, cancer follow-up, or an in-person exam when one is needed. People with complex surgical histories or higher-risk conditions may need coordinated care with their surgeon, gynecologist, oncologist, or primary-care clinician.
3-min quiz
Start with a clinician-reviewed HRT evaluation
Complete Chia's online health questionnaire to discuss surgical menopause, symptoms, and possible treatment options with a licensed US provider. A prescription requires a medical evaluation and is not guaranteed. If clinically appropriate, medication is compounded by a US state-licensed 503A pharmacy and delivered to your door; compounded drugs are not FDA-approved 1. Review estradiol options before your visit.
What are common questions about HRT after surgical menopause?
Possibly, but a clinician needs to review your health history and surgery details. When a uterus remains, systemic estrogen usually requires a discussion about adding a progestogen for endometrial protection 1.
Not necessarily. Hysterectomy removes the uterus, but retained ovaries may continue producing hormones 1. HRT may be considered later for menopause symptoms or another clinical reason, not simply because a hysterectomy occurred.
Ask your surgeon or menopause clinician before surgery when possible, or soon after surgery if symptoms begin or you have questions about bone health. The best timing depends on the reason for surgery, recovery needs, and your medical history 1.
It can be. If both ovaries were removed, the hormone change is abrupt. If the uterus was also removed, estrogen-only therapy may be considered in some people because endometrial protection is not needed. A clinician still needs to assess other risks 1.
A clinician commonly considers a progestogen with systemic estrogen when the uterus remains because estrogen can stimulate the uterine lining. The right medication, route, and regimen are individual medical decisions 1.
Hormone therapy can help prevent bone loss while it is used in appropriate patients, but it does not guarantee protection from osteoporosis or fractures 1. Your clinician may also discuss bone-density testing and other bone-health steps.
No. Compounded medications are not FDA-approved 1. At Chia, any prescribed compounded medication is prepared by a US state-licensed 503A compounding pharmacy after a licensed clinician's review.
An online clinician may be able to evaluate you and prescribe where clinically appropriate, depending on your history and state requirements. Some situations require in-person examination, specialist coordination, or urgent care.
References
- 1.The Menopause Society. The benefits and risks of menopause hormone therapy for women: a patient-centered approach. 2024.
- 2.Dresner-Pollak R, Mayer M, Hochner-Celiniker D. The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women. Calcified Tissue International. 2000.
- 3.Delmas P, Gimona A. Osteoporosis prevention clinical study program. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 1996.
- 4.Castelo-Branco C, Figueras F, Sanjuan A, et al. Long-term postmenopausal hormone replacement therapy effects on bone mass: differences between surgical and spontaneous patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 1999.
- 5.Lau TK, Wan D, Yim SF, et al. Prospective, randomized, controlled study of the effect of hormone replacement therapy on peripheral blood flow velocity in postmenopausal women. Fertility and Sterility. 1998.
- 6.Erel CT, Gezer A, Sentürk LM, et al. Effect of different hormonal therapies on thyroid function in surgical menopause: short-term results. Journal of Reproductive Medicine. 2007.
- 7.Colacurci N, Fornaro F, De Franciscis P, et al. Effects of a short-term suspension of hormone replacement therapy on mammographic density. Fertility and Sterility. 2001.
- 8.National Library of Medicine. The Benefits and Risks of Different Menopausal Hormone Therapy Treatments. ClinicalTrials.gov study NCT03436303. 2018.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if hormone therapy is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
